✦ LIBER ✦

Trends in US approvals: new biopharmaceuticals and vaccines

✍ Scribed by Janice M. Reichert

Book ID: 113931996
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 140 KB
Volume: 24
Category: Article
ISSN: 0167-7799
DOI: 10.1016/j.tibtech.2006.05.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New biopharmaceuticals in the USA: trend

New biopharmaceuticals in the USA: trends in development and marketing approvals 1995–1999

✍ Janice M Reichert 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Early US approval for new pertussis vacc

Early US approval for new pertussis vaccine?

✍ Alicia Ault Burnett 📂 Article 📅 1995 🏛 The Lancet 🌐 English ⚖ 198 KB

Approval of new biopharmaceuticals 1999–

Approval of new biopharmaceuticals 1999–2006: Comparison of the US, EU and Japan situations

✍ Kaori Tsuji; Kiichiro Tsutani 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 138 KB

New trends in carbohydrate-based vaccine

New trends in carbohydrate-based vaccines

✍ René Roy 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 406 KB

US drug and biologic approvals in 1998

✍ Bert Spilker; Stacey FitzSimmons; Michael Horan 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 1 views

The Prescription Drug User Fee Act of 1992 enhanced review resources for the Food and Drug Administration (FDA). The past 3 years have seen an unprecedented approval of 122 new drugs and 28 new biologics. Information is provided on the 39 new products approved by the

US drug and biologic approvals in 1997

✍ John F. Beary III; John D. Siegfried; Renee Tavares 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 837 KB

The Prescription Drug User Fee Act of 1992 enhanced review resources for the Food and Drug Administration (FDA). The past two years have seen an unprecedented approval of 92 new drugs and 19 new biologics. Information is provided on the 49 new products approved by the FDA in 1997.